104 related articles for article (PubMed ID: 16476141)
1. Aripiprazole-induced extrapyramidal side effects in a patient with schizoaffective disorder.
Ziegenbein M; Sieberer M; Calliess IT; Kropp S
Aust N Z J Psychiatry; 2006 Feb; 40(2):194-5. PubMed ID: 16476141
[No Abstract] [Full Text] [Related]
2. Aripiprazole-induced rabbit syndrome.
Mendhekar DN
Aust N Z J Psychiatry; 2004 Jul; 38(7):561. PubMed ID: 15255832
[No Abstract] [Full Text] [Related]
3. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
Glick ID; Mankoski R; Eudicone JM; Marcus RN; Tran QV; Assunção-Talbott S
J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981
[TBL] [Abstract][Full Text] [Related]
4. Do dopamine partial agonists have partial efficacy as antipsychotics?
Stahl SM
CNS Spectr; 2008 Apr; 13(4):279-82. PubMed ID: 18408646
[No Abstract] [Full Text] [Related]
5. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
[TBL] [Abstract][Full Text] [Related]
6. Worsening schizoaffective disorder with aripiprazole.
Reeves RR; Mack JE
Am J Psychiatry; 2004 Jul; 161(7):1308. PubMed ID: 15229073
[No Abstract] [Full Text] [Related]
7. Extrapyramidal side effects associated with aripiprazole coprescription in 2 patients.
Cohen ST; Rulf D; Pies R
J Clin Psychiatry; 2005 Jan; 66(1):135-6. PubMed ID: 15669901
[No Abstract] [Full Text] [Related]
8. Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole.
Raja M
Int J Neuropsychopharmacol; 2007 Feb; 10(1):107-10. PubMed ID: 16487453
[TBL] [Abstract][Full Text] [Related]
9. Aripiprazole in the treatment of Alzheimer's disease.
De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
Kwon JS; Jang JH; Kang DH; Yoo SY; Kim YK; Cho SJ;
Psychiatry Clin Neurosci; 2009 Feb; 63(1):73-81. PubMed ID: 19154213
[TBL] [Abstract][Full Text] [Related]
11. Safety, tolerability, and self-rated effects of aripiprazole and ropinirole treatment for cocaine dependence: a pilot study.
Meini M; Moncini M; Cecconi D; Cellesi V; Biasci L; Simoni G; Ameglio M; Pellegrini M; Forgione RN; Rucci P
Am J Addict; 2011; 20(2):179-80. PubMed ID: 21314764
[No Abstract] [Full Text] [Related]
12. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
[TBL] [Abstract][Full Text] [Related]
13. The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out.
Citrome L
Int J Clin Pract; 2015 Nov; 69(11):1211-20. PubMed ID: 26477545
[No Abstract] [Full Text] [Related]
14. Oculogyric crisis: a rare extrapyramidal side effect in the treatment of Tourette syndrome.
Rizzo R; Gulisano M; Calì PV
Eur Child Adolesc Psychiatry; 2012 Oct; 21(10):591-2. PubMed ID: 22692815
[No Abstract] [Full Text] [Related]
15. Aripiprazole: does partial dopaminergic agonism translate into clinical benefits?
Crismon ML; DeLeon A; Miller AL
Ann Pharmacother; 2003 May; 37(5):738-40. PubMed ID: 12708954
[No Abstract] [Full Text] [Related]
16. Aripiprazole as a dopamine partial agonist: positive and negative effects.
Glick ID; Duggal V; Hodulik C
J Clin Psychopharmacol; 2006 Feb; 26(1):101-3. PubMed ID: 16415723
[No Abstract] [Full Text] [Related]
17. Aripiprazole's receptor pharmacology and extrapyramidal side effects.
Poyurovsky M; Weizman R; Weizman A
Am J Psychiatry; 2008 Mar; 165(3):398; author reply 398-9. PubMed ID: 18316435
[No Abstract] [Full Text] [Related]
18. Hiccups associated with switching from olanzapine to aripiprazole in a patient with paranoid schizophrenia.
Hori H; Nakamura J
Clin Neuropharmacol; 2014; 37(3):88-9. PubMed ID: 24824665
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole-induced movement disorder.
Zacher JL; Hatchett AD
Am J Psychiatry; 2006 Jan; 163(1):160-1. PubMed ID: 16390909
[No Abstract] [Full Text] [Related]
20. Partial dopamine agonists in schizophrenia.
Launer M
Hosp Med; 2005 May; 66(5):300-3. PubMed ID: 15920862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
